ArticleSignal transduction and targeted therapy2023

Nuclear AhR and membranous PD-L1 in predicting response of non-small cell lung cancer to PD-1 blockade.

Si-Chong Han et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.